Adipotide FTPP (10mg)

Product Category

Targeted Lipolytic Peptides, Pro-Apoptotic Factors & Weight Management Modulators

Action on the Human Body

Adipotide (FTPP) is an experimental synthetic peptidomimetic engineered to target and eliminate vascular networks feeding white fat cells. The molecule consists of a homing domain that binds selectively to prohibitin, a membrane protein uniquely overexpressed on the endothelial cells of blood vessels servicing white adipose tissues, linked to a pro-apoptotic domain, synthetic peptide sequence (KLAKLAK)2. Upon binding, Adipotide undergoes receptor-mediated endocytosis, introducing the pro-apoptotic sequence into the endothelial cell cytoplasm. This disrupts mitochondrial membrane stability, initiating programmed cell death cascades exclusively within the targeted fat-servicing vasculature. Denied essential nutrient and oxygen delivery, the associated white adipocytes undergo rapid atrophy, necrosis, and systemic clearance via phagocytosis. This selective mechanism promotes profound lipid loss without disrupting structural lean mass or taxing the central nervous system.

What to Expect if Consumed

Expect a targeted down-regulation of stubborn visceral fat reserves, an immediate improvement in systemic insulin sensitivity pathways, enhanced basal metabolic rates, and an accelerated shifting of body composition metrics without classical stimulant jitters.

Possible Therapy Combinations

Can be successfully layered with MOTS-C to amplify overall mitochondrial energy expenditure, or combined with NAD+ to maintain high baseline cellular vitality parameters during intensive fat reduction cycles.

Molecular Formula & Chemical Composition

Molecular Formula: C111H204N36O28S2. Sequence: H-Cys-Lys-Gly-Gly-Arg-Ala-Pro-Arg-Cys-Gly-Gly-D(Lys-Leu-Ala-Lys-Leu-Ala-Lys)2-NH2 (Disulfide Bridge). Purity: >99% Pure Lyophilized Mass.

WARNING: This peptide compound must be handled and utilized exclusively under very high, correct professional and qualified medical supervision. Misuse can lead to unintended biological variations.

Scientific References

1. Barnhart, K. F., et al. (2011). ‘A peptidomimetic targeting white fat vasculature induces weight loss in obese nonhuman primates.’ Science Translational Medicine.
2. Kolonin, M., et al. (2004). ‘Reversal of obesity by targeted ablation of adipose tissue vasculature.’ Nature Medicine.